| 1 | The Evolutionary Forest of Pancreatic Cancer | 25.1 | 14 | Citations (PDF) |
| 2 | Role of clonal inflammatory microglia in histiocytosis-associated neurodegenerationNeuron, 2025, 113, 1065-1081.e13 | 11.0 | 5 | Citations (PDF) |
| 3 | The nuclear factor ID3 endows macrophages with a potent anti-tumour activity | 37.9 | 52 | Citations (PDF) |
| 4 | A microglia clonal inflammatory disorder in Alzheimer’s disease | 1.6 | 4 | Citations (PDF) |
| 5 | Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response | 6.3 | 28 | Citations (PDF) |
| 6 | A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier | 6.8 | 7 | Citations (PDF) |
| 7 | Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer | 33.0 | 38 | Citations (PDF) |
| 8 | A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1α Nuclear Retention | 25.1 | 9 | Citations (PDF) |
| 9 | Islands of genomic stability in the face of genetically unstable metastatic cancer | 2.3 | 2 | Citations (PDF) |
| 10 | Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer | 13.7 | 24 | Citations (PDF) |
| 11 | Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma | 6.8 | 19 | Citations (PDF) |
| 12 | Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms | 3.9 | 6 | Citations (PDF) |
| 13 | STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma | 37.9 | 180 | Citations (PDF) |
| 14 | Clonal evolution during metastatic spread in high-risk neuroblastoma | 25.2 | 42 | Citations (PDF) |
| 15 | Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse | 12.5 | 15 | Citations (PDF) |
| 16 | The Ratio of Key Metabolic Transcripts Is a Predictive Biomarker of Breast Cancer Metastasis to the Lung | 3.8 | 12 | Citations (PDF) |
| 17 | Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma | 3.8 | 17 | Citations (PDF) |
| 18 | MYC
Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma | 25.1 | 91 | Citations (PDF) |
| 19 | Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patientsCell, 2022, 185, 563-575.e11 | 33.7 | 524 | Citations (PDF) |
| 20 | Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts | 13.7 | 44 | Citations (PDF) |
| 21 | Evidence for reduced BRCA2 functional activity in Homo sapiens after divergence from the chimpanzee-human last common ancestor | 6.3 | 8 | Citations (PDF) |
| 22 | Neoantigen quality predicts immunoediting in survivors of pancreatic cancer | 37.9 | 169 | Citations (PDF) |
| 23 | Concurrent GermlineBRCA1/2and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options | 1.9 | 4 | Citations (PDF) |
| 24 | Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State | 3.8 | 8 | Citations (PDF) |
| 25 | Ordered and deterministic cancer genome evolution after p53 loss | 37.9 | 200 | Citations (PDF) |
| 26 | Clinico-genomic Characterization of
ATM
and HRD in Pancreas Cancer: Application for Practice | 6.8 | 27 | Citations (PDF) |
| 27 | BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling | 13.7 | 57 | Citations (PDF) |
| 28 | MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis | 22.5 | 95 | Citations (PDF) |
| 29 | Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer | 0.9 | 142 | Citations (PDF) |
| 30 | Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients | 33.0 | 68 | Citations (PDF) |
| 31 | Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001 | 6.8 | 10 | Citations (PDF) |
| 32 | Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes | 4.6 | 53 | Citations (PDF) |
| 33 | Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma | 2.9 | 29 | Citations (PDF) |
| 34 | Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility | 13.7 | 30 | Citations (PDF) |
| 35 | Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation | 25.1 | 148 | Citations (PDF) |
| 36 | The pancreatic cancer genome revisited | 45.8 | 175 | Citations (PDF) |
| 37 | Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes | 4.0 | 38 | Citations (PDF) |
| 38 | The mutational landscape of human somatic and germline cells | 37.9 | 337 | Citations (PDF) |
| 39 | The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas | 6.8 | 12 | Citations (PDF) |
| 40 | Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer | 0.9 | 29 | Citations (PDF) |
| 41 | ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer | 25.1 | 74 | Citations (PDF) |
| 42 | A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma | 22.5 | 181 | Citations (PDF) |
| 43 | Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis | 36.2 | 255 | Citations (PDF) |
| 44 | Accelerated single cell seeding in relapsed multiple myeloma | 13.7 | 64 | Citations (PDF) |
| 45 | Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma | 7.5 | 23 | Citations (PDF) |
| 46 | Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis | 13.7 | 28 | Citations (PDF) |
| 47 | HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer | 6.3 | 116 | Citations (PDF) |
| 48 | Simple mucinous cysts of the pancreas have heterogeneous somatic mutations | 2.3 | 17 | Citations (PDF) |
| 49 | Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune CellsCell, 2020, 181, 1643-1660.e17 | 33.7 | 872 | Citations (PDF) |
| 50 | Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma | 4.0 | 66 | Citations (PDF) |
| 51 | The Evolutionary Origins of Recurrent Pancreatic Cancer | 25.1 | 97 | Citations (PDF) |
| 52 | Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma | 4.8 | 54 | Citations (PDF) |
| 53 | The mutational landscape of normal human endometrial epithelium | 37.9 | 445 | Citations (PDF) |
| 54 | iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy | 3.8 | 46 | Citations (PDF) |
| 55 | Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection | 6.8 | 199 | Citations (PDF) |
| 56 | Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor | 10.6 | 42 | Citations (PDF) |
| 57 | Stakeholders' Perceptions and Information Needs Regarding Research Medical Donation | 0.8 | 2 | Citations (PDF) |
| 58 | CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma | 1.7 | 48 | Citations (PDF) |
| 59 | An analysis of genetic heterogeneity in untreated cancers | 60.8 | 192 | Citations (PDF) |
| 60 | Cancer biology as revealed by the research autopsy | 60.8 | 75 | Citations (PDF) |
| 61 | Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence | 7.5 | 82 | Citations (PDF) |
| 62 | Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood | 3.9 | 146 | Citations (PDF) |
| 63 | Characterization of genetic subclonal evolution in pancreatic cancer mouse models | 13.7 | 23 | Citations (PDF) |
| 64 | Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship | 0.3 | 0 | Citations (PDF) |
| 65 | <i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i>-Amplified Esophagogastric Cancer | 25.1 | 140 | Citations (PDF) |
| 66 | Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes | 4.0 | 39 | Citations (PDF) |
| 67 | Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer | 7.5 | 301 | Citations (PDF) |
| 68 | Abstract I07: Multimodal evolutionary dynamics of pancreatic cancer 2019, , | | 0 | Citations (PDF) |
| 69 | Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms | 4.6 | 211 | Citations (PDF) |
| 70 | Unifying cancer and normal RNA sequencing data from different sources | 5.7 | 209 | Citations (PDF) |
| 71 | Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation | 0.9 | 32 | Citations (PDF) |
| 72 | Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations | 6.8 | 338 | Citations (PDF) |
| 73 | The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers | 33.0 | 863 | Citations (PDF) |
| 74 | Precancerous neoplastic cells can move through the pancreatic ductal system | 37.9 | 119 | Citations (PDF) |
| 75 | Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases | 36.2 | 237 | Citations (PDF) |
| 76 | Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer | 25.1 | 951 | Citations (PDF) |
| 77 | Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis | 0.9 | 112 | Citations (PDF) |
| 78 | Reconstructing metastatic seeding patterns of human cancers | 13.7 | 135 | Citations (PDF) |
| 79 | Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis | 25.2 | 445 | Citations (PDF) |
| 80 | Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer | 25.2 | 382 | Citations (PDF) |
| 81 | Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy | 6.8 | 76 | Citations (PDF) |
| 82 | Alterations of type II classical cadherin, cadherin‐10 (CDH10), is associated with pancreatic ductal adenocarcinomas | 3.0 | 11 | Citations (PDF) |
| 83 | Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling | 3.8 | 12 | Citations (PDF) |
| 84 | Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype | 6.8 | 192 | Citations (PDF) |
| 85 | Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer | 37.9 | 1,065 | Citations (PDF) |
| 86 | An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course | 1.4 | 7 | Citations (PDF) |
| 87 | Hypermutation In Pancreatic Cancer | 0.9 | 199 | Citations (PDF) |
| 88 | Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer | 6.8 | 43 | Citations (PDF) |
| 89 | Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing | 4.6 | 53 | Citations (PDF) |
| 90 | ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer | 0.9 | 54 | Citations (PDF) |
| 91 | Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma | 4.6 | 143 | Citations (PDF) |
| 92 | p120 Catenin Suppresses Basal Epithelial Cell Extrusion in Invasive Pancreatic Neoplasia | 3.8 | 36 | Citations (PDF) |
| 93 | TGF-β Tumor Suppression through a Lethal EMTCell, 2016, 164, 1015-1030 | 33.7 | 574 | Citations (PDF) |
| 94 | Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression | 33.0 | 551 | Citations (PDF) |
| 95 | Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms | 6.8 | 5 | Citations (PDF) |
| 96 | Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas | 2.9 | 78 | Citations (PDF) |
| 97 | Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer | 2.7 | 25 | Citations (PDF) |
| 98 | Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies | 6.3 | 558 | Citations (PDF) |
| 99 | Pancreatic cancer biology and genetics from an evolutionary perspective | 60.8 | 369 | Citations (PDF) |
| 100 | Metastatic progression is associated with dynamic changes in the local microenvironment | 13.7 | 118 | Citations (PDF) |
| 101 | IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers | 4.6 | 24 | Citations (PDF) |
| 102 | The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes | 4.8 | 100 | Citations (PDF) |
| 103 | Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer | 25.1 | 334 | Citations (PDF) |
| 104 | Genomic analyses identify molecular subtypes of pancreatic cancer | 37.9 | 3,324 | Citations (PDF) |
| 105 | Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy | 3.7 | 37 | Citations (PDF) |
| 106 | Whole Exome Sequencing from Nine Independent Sites of Extraosseous Disease in a Single Patient with Relapsed Multiple Myeloma Show That Extramedullary Disease Arise through a Combination of Branched and Parallel EvolutionBlood, 2016, 128, 2090-2090 | 4.2 | 0 | Citations (PDF) |
| 107 | Transflip mutations produce deletions in pancreatic cancer | 3.0 | 10 | Citations (PDF) |
| 108 | The Hidden Beauty in Biomedical Imaging | 0.9 | 1 | Citations (PDF) |
| 109 | Organoid Models of Human and Mouse Ductal Pancreatic Cancer | 33.7 | 1,988 | Citations (PDF) |
| 110 | Whole genomes redefine the mutational landscape of pancreatic cancer | 37.9 | 2,465 | Citations (PDF) |
| 111 | Are We Systematically Under-Dosing Patients With Fluorouracil? | 16.9 | 8 | Citations (PDF) |
| 112 | Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer | 5.4 | 110 | Citations (PDF) |
| 113 | Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma | 4.0 | 506 | Citations (PDF) |
| 114 | Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma | 33.0 | 146 | Citations (PDF) |
| 115 | Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution | 4.6 | 136 | Citations (PDF) |
| 116 | A Quantitative System for Studying Metastasis Using Transparent Zebrafish | 3.8 | 130 | Citations (PDF) |
| 117 | Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma | 25.2 | 1,955 | Citations (PDF) |
| 118 | MUC1 Promoter–Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer | 3.1 | 18 | Citations (PDF) |
| 119 | p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells | 6.5 | 132 | Citations (PDF) |
| 120 | Abstract A68: Hypoxia-induced CHK1 repression may enhance the mutator phenotype of pancreatic cancer cells 2015, , | | 0 | Citations (PDF) |
| 121 | Processed pseudogenes acquired somatically during cancer development | 13.7 | 103 | Citations (PDF) |
| 122 | CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas | 3.0 | 7 | Citations (PDF) |
| 123 | The Tumor Suppressor
rpl36
Restrains KRAS
G12V
-Induced Pancreatic Cancer | 1.4 | 26 | Citations (PDF) |
| 124 | dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer | 4.1 | 40 | Citations (PDF) |
| 125 | Functional p38 MAPK Identified by Biomarker Profiling of Pancreatic Cancer Restrains Growth through JNK Inhibition and Correlates with Improved Survival | 6.8 | 42 | Citations (PDF) |
| 126 | Autophagy, p53, and Pancreatic Cancer | 34.6 | 38 | Citations (PDF) |
| 127 | The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation | 1.7 | 10 | Citations (PDF) |
| 128 | Long Interspersed Element-1 Protein Expression Is a Hallmark of Many Human Cancers | 3.4 | 334 | Citations (PDF) |
| 129 | A draft map of the human proteome | 37.9 | 2,162 | Citations (PDF) |
| 130 | Heterogeneity of Pancreatic Cancer Metastases in a Single Patient Revealed by Quantitative Proteomics | 3.0 | 56 | Citations (PDF) |
| 131 | Hypersensitivities for Acetaldehyde and Other Agents among Cancer Cells Null for Clinically Relevant Fanconi Anemia Genes | 3.4 | 13 | Citations (PDF) |
| 132 | Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma | 33.0 | 1,874 | Citations (PDF) |
| 133 | CNS Involvement in Pancreatic Adenocarcinoma: a Report of Eight Cases from the Johns Hopkins Hospital and Review of Literature | 1.2 | 25 | Citations (PDF) |
| 134 | Molecular pathways in pancreatic carcinogenesis | 1.5 | 73 | Citations (PDF) |
| 135 | Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer | 6.8 | 153 | Citations (PDF) |
| 136 | Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships | 0.4 | 78 | Citations (PDF) |
| 137 | Pancreatic cancer genomics: insights and opportunities for clinical translation | 9.6 | 19 | Citations (PDF) |
| 138 | KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma | 4.3 | 13 | Citations (PDF) |
| 139 | FAM190A Deficiency Creates a Cell Division Defect | 3.4 | 29 | Citations (PDF) |
| 140 | Correlation of Smad4 Status With Outcomes in Patients Receiving Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy After Resection for Pancreatic Adenocarcinoma | 1.5 | 22 | Citations (PDF) |
| 141 | Evolution and dynamics of pancreatic cancer progression | 6.5 | 177 | Citations (PDF) |
| 142 | A Broad Survey of Cathepsin K Immunoreactivity in Human Neoplasms | 0.7 | 50 | Citations (PDF) |
| 143 | RhoC Interacts with Integrin α5β1 and Enhances Its Trafficking in Migrating Pancreatic Carcinoma Cells | 2.3 | 21 | Citations (PDF) |
| 144 | Clinicopathologic and Genetic Characterization of Traditional Serrated Adenomas of the Colon | 0.7 | 62 | Citations (PDF) |
| 145 | The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma | 37.9 | 317 | Citations (PDF) |
| 146 | CpG Island Methylator Phenotype–Positive Tumors in the Absence of
MLH1
Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis | 6.8 | 49 | Citations (PDF) |
| 147 | Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project | 16.8 | 142 | Citations (PDF) |
| 148 | Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors | 3.5 | 520 | Citations (PDF) |
| 149 | Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors | 6.8 | 254 | Citations (PDF) |
| 150 | A new branch on the tree: Next-generation sequencing in the study of cancer evolution | 5.4 | 34 | Citations (PDF) |
| 151 | Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies | 33.7 | 396 | Citations (PDF) |
| 152 | Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes | 37.9 | 1,915 | Citations (PDF) |
| 153 | Sessile serrated adenomas: high-risk lesions? | 2.3 | 25 | Citations (PDF) |
| 154 | Personalized Medicine in Pancreatic Cancer: Prognosis and Potential Implications for Therapy | 1.7 | 3 | Citations (PDF) |
| 155 | HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells | 2.3 | 98 | Citations (PDF) |
| 156 | Genetically Defined Subsets of Human Pancreatic Cancer Show Unique
In Vitro
Chemosensitivity | 6.8 | 66 | Citations (PDF) |
| 157 | DNA methylation biomarker candidates for early detection of colon cancer | 1.2 | 64 | Citations (PDF) |
| 158 | Young Patients Undergoing Resection of Pancreatic Cancer Fare Better than their Older Counterparts | 1.7 | 61 | Citations (PDF) |
| 159 | Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples | 2.3 | 46 | Citations (PDF) |
| 160 | Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis | 37.9 | 2,081 | Citations (PDF) |
| 161 | Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes | 3.4 | 499 | Citations (PDF) |
| 162 | Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development | 33.7 | 2,267 | Citations (PDF) |
| 163 | AGR2 Is a Novel Surface Antigen That Promotes the Dissemination of Pancreatic Cancer Cells through Regulation of Cathepsins B and D | 3.8 | 139 | Citations (PDF) |
| 164 | Establishment and Characterization of a New Cell Line, A99, From a Primary Small Cell Carcinoma of the Pancreas | 0.9 | 22 | Citations (PDF) |
| 165 | Histologic Variations in Juvenile Polyp Phenotype Correlate With Genetic Defect Underlying Juvenile Polyposis | 3.5 | 40 | Citations (PDF) |
| 166 | Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract | 4.3 | 53 | Citations (PDF) |
| 167 | Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer | 6.8 | 144 | Citations (PDF) |
| 168 | Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas | 4.8 | 94 | Citations (PDF) |
| 169 | GATA6 Activates Wnt Signaling in Pancreatic Cancer by Negatively Regulating the Wnt Antagonist Dickkopf-1 | 2.3 | 92 | Citations (PDF) |
| 170 | Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas | 4.6 | 220 | Citations (PDF) |
| 171 | Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer | 5.5 | 71 | Citations (PDF) |
| 172 | Heteroplasmic mitochondrial DNA mutations in normal and tumour cells | 37.9 | 494 | Citations (PDF) |
| 173 | The patterns and dynamics of genomic instability in metastatic pancreatic cancer | 37.9 | 1,261 | Citations (PDF) |
| 174 | Distant metastasis occurs late during the genetic evolution of pancreatic cancer | 37.9 | 2,329 | Citations (PDF) |
| 175 | Cross-platform Comparison of Two Pancreatic Cancer Phenotypes | 1.9 | 1 | Citations (PDF) |
| 176 | Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma | 4.6 | 405 | Citations (PDF) |
| 177 | A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma | 8.1 | 217 | Citations (PDF) |
| 178 | Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer | 2.6 | 19 | Citations (PDF) |
| 179 | Cronkhite-Canada Syndrome: Gastric Involvement Diagnosed by MDCT | 0.7 | 11 | Citations (PDF) |
| 180 | Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: Potential contributors to IBD-associated diarrhea | 2.9 | 118 | Citations (PDF) |
| 181 | Epigenetic Changes in Cancer | 30.6 | 157 | Citations (PDF) |
| 182 | Increased Cyclooxygenase-2 Expression in Juvenile Polyposis Syndrome | 6.0 | 15 | Citations (PDF) |
| 183 | Beta-catenin Nuclear Labeling is a Common Feature of Sessile Serrated Adenomas and Correlates With Early Neoplastic Progression After BRAF Activation | 3.5 | 103 | Citations (PDF) |
| 184 | HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma | 4.8 | 80 | Citations (PDF) |
| 185 | The Pathology and Genetics of Metastatic Pancreatic Cancer | 2.4 | 209 | Citations (PDF) |
| 186 | Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9 | 4.8 | 28 | Citations (PDF) |
| 187 | Occurrence of Colorectal Adenomas in Younger Adults: An Epidemiologic Necropsy Study | 6.0 | 66 | Citations (PDF) |
| 188 | Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma | 4.1 | 68 | Citations (PDF) |
| 189 | Copy number alterations in pancreatic cancer identify recurrentPAK4amplification | 4.1 | 123 | Citations (PDF) |
| 190 | Increased expression of cytoplasmic HuR in familial adenomatous polyposis | 4.1 | 27 | Citations (PDF) |
| 191 | Frequent β-Catenin Nuclear Labeling in Sessile Serrated Polyps of the Colorectum With Neoplastic Potential | 0.7 | 47 | Citations (PDF) |
| 192 | Patchy Distribution of Pathologic Abnormalities in Autoimmune Pancreatitis | 3.5 | 35 | Citations (PDF) |
| 193 | HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma | 4.8 | 100 | Citations (PDF) |
| 194 | Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk | 7.5 | 98 | Citations (PDF) |
| 195 | Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types | 4.1 | 34 | Citations (PDF) |
| 196 | Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma | 16.9 | 383 | Citations (PDF) |
| 197 | Aberrant methylation ofReprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma | 4.0 | 48 | Citations (PDF) |
| 198 | When should one subtract background fluorescence in 2-color microarrays? | 2.1 | 23 | Citations (PDF) |
| 199 | Identifying Allelic Loss and Homozygous Deletions in Pancreatic Cancer without Matched Normals Using High-Density Single-Nucleotide Polymorphism Arrays | 3.8 | 79 | Citations (PDF) |
| 200 | Sessile Serrated Adenomas With Low- and High-Grade Dysplasia and Early Carcinomas | 0.7 | 164 | Citations (PDF) |
| 201 | Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status | 2.6 | 58 | Citations (PDF) |
| 202 | Nuclear β-Catenin Expression Distinguishes Deep Fibromatosis From Other Benign and Malignant Fibroblastic and Myofibroblastic Lesions | 3.5 | 324 | Citations (PDF) |
| 203 | RPL38, FOSL1, and UPP1 Are Predominantly Expressed in the Pancreatic Ductal Epithelium | 0.9 | 32 | Citations (PDF) |
| 204 | Assessment of epidermal growth factor receptor (EGFR) signaling in paired colorectal cancer and normal colon tissue samples using computer-aided immunohistochemical analysis | 4.1 | 36 | Citations (PDF) |
| 205 | Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy | 4.1 | 142 | Citations (PDF) |
| 206 | Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: A potential new target for therapy | 4.1 | 84 | Citations (PDF) |
| 207 | Stromal responses to carcinomas of the pancreas: Juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype | 4.1 | 36 | Citations (PDF) |
| 208 | Pancreaticobiliary Cancers With Deficient Methylenetetrahydrofolate Reductase Genotypes | 6.0 | 40 | Citations (PDF) |
| 209 | Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer | 0.7 | 152 | Citations (PDF) |
| 210 | Gene expression profiling identifies markers of ampullary adenocarcinoma | 4.1 | 35 | Citations (PDF) |
| 211 | Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients | 7.5 | 180 | Citations (PDF) |
| 212 | Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression | 4.1 | 75 | Citations (PDF) |
| 213 | Gene Expression Profiling Identifies Genes Associated with Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas | 3.4 | 197 | Citations (PDF) |
| 214 | Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays | 2.3 | 138 | Citations (PDF) |
| 215 | Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms | 3.5 | 456 | Citations (PDF) |
| 216 | Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma | 6.5 | 155 | Citations (PDF) |
| 217 | Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma | 1.1 | 175 | Citations (PDF) |
| 218 | Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis | 33.0 | 638 | Citations (PDF) |
| 219 | Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray | 4.8 | 382 | Citations (PDF) |
| 220 | Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays | 3.4 | 463 | Citations (PDF) |
| 221 | Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas | 2.8 | 151 | Citations (PDF) |
| 222 | Gene Expression in Neoplasms of the Pancreas: Applications to Diagnostic Pathology | 2.3 | 13 | Citations (PDF) |
| 223 | Title is missing! | 4.6 | 25 | Citations (PDF) |
| 224 | Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis | 4.6 | 190 | Citations (PDF) |
| 225 | Immunohistochemical Validation of a Novel Epithelial and a Novel Stromal Marker of Pancreatic Ductal Adenocarcinoma Identified by Global Expression Microarrays | 0.7 | 130 | Citations (PDF) |
| 226 | Almost All Infiltrating Colloid Carcinomas of the Pancreas and Periampullary Region Arise From In Situ Papillary Neoplasms | 3.5 | 142 | Citations (PDF) |
| 227 | Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology | 3.4 | 275 | Citations (PDF) |
| 228 | Exploring the Host Desmoplastic Response to Pancreatic Carcinoma | 3.4 | 189 | Citations (PDF) |
| 229 | Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas | 0.9 | 131 | Citations (PDF) |
| 230 | Reed-Sternberg-like cells in lymph node aspirates in the absence of Hodgkin's disease: Pathologic significance and differential diagnosis | 1.1 | 26 | Citations (PDF) |
| 231 | Pancreatic cancer | 2.0 | 270 | Citations (PDF) |
| 232 | Colloid Carcinomas of the Pancreas and Periampullary Region | 3.5 | 3 | Citations (PDF) |
| 233 | Colchicine Effect in a Colonic Hyperplastic Polyp | 2.4 | 12 | Citations (PDF) |
| 234 | STK11/LKB1 Peutz-Jeghers Gene Inactivation in Intraductal Papillary-Mucinous Neoplasms of the Pancreas | 3.4 | 261 | Citations (PDF) |
| 235 | Colchicine Toxicity | 3.5 | 159 | Citations (PDF) |
| 236 | Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Increasingly Recognized Clinicopathologic Entity | 4.6 | 291 | Citations (PDF) |
| 237 | Dpc4 Protein in Mucinous Cystic Neoplasms of the Pancreas | 3.5 | 167 | Citations (PDF) |
| 238 | Dpc-4 Protein Is Expressed in Virtually All Human Intraductal Papillary Mucinous Neoplasms of the Pancreas | 3.4 | 252 | Citations (PDF) |
| 239 | Cathepsin B Activity and Protein Levels in Thyroid Carcinoma, Graves' Disease, and Multinodular Goiters | 4.4 | 27 | Citations (PDF) |
| 240 | Cytomegaloviral enterocolitis | 1.7 | 103 | Citations (PDF) |
| 241 | Elevations in Cathepsin B Protein Content and Enzyme Activity Occur Independently of Glycosylation during Colorectal Tumor Progression | 2.2 | 48 | Citations (PDF) |
| 242 | Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches | 2.3 | 43 | Citations (PDF) |
| 243 | Title is missing! 0 | | 2 | Citations (PDF) |
| 244 | Title is missing! 0 | | 1 | Citations (PDF) |
| 245 | A microglia clonal inflammatory disorder in Alzheimer’s disease | 1.6 | 5 | Citations (PDF) |
| 246 | SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence | 22.5 | 3 | Citations (PDF) |
| 247 | Safety and Feasibility of Intra-Arterial Treatment of Pancreatic Cancer Using an Emulsion of Ethiodized Oil plus Bumetanide in an Oncopig Model | 1.1 | 0 | Citations (PDF) |
| 248 | Genomic evolution of pancreatic cancer at single-cell resolution | 25.2 | 0 | Citations (PDF) |
| 249 | Dual pancreatic carcinomas: clonally related or independent primaries? | 6.5 | 0 | Citations (PDF) |
